| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VCEL | Vericel Corp | Wotton Paul K | Director | Dec 14, 2023 | Sale | $37.31 | 5,000 | 186,550 | 26,802 | Dec 15, 2023, 04:07 PM | |
| VCEL | Vericel Corp | Wotton Paul K | Director | May 11, 2021 | Sale | $22.93 | 57,198 | 1,311,535 | 47,250 | May 13, 2021, 04:50 PM | |
| VCEL | Vericel Corp | Wotton Paul K | Director | May 12, 2021 | Sale | $48.88 | 2,200 | 107,534 | 31,602 | May 13, 2021, 04:50 PM | |
| VCEL | Vericel Corp | Wotton Paul K | Director | Jan 02, 2019 | Sale | $9.74 | 45,000 | 438,518 | 17,500 | Jan 04, 2019, 04:13 PM | |
| VCEL | Vericel Corp | Wotton Paul K | Director | Jun 18, 2018 | Sale | $7.74 | 60,000 | 464,200 | 30,000 | Jun 20, 2018, 02:05 PM | |
| OCAT | Ocata Therapeutics, Inc. | Wotton Paul K | President and CEO | Feb 10, 2016 | Option Exercise | $8.50 | 277,500 | 2,358,750 | 0 | Feb 11, 2016, 04:26 PM | |
| OCAT | Ocata Therapeutics, Inc. | Wotton Paul K | President and CEO | Jul 30, 2015 | Option Exercise | $4.23 | 32,500 | 137,475 | 267,500 | Jul 31, 2015, 04:14 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Feb 20, 2014 | Option Exercise | $4.85 | 3,309 | 16,049 | 670,734 | Feb 24, 2014, 05:51 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Feb 11, 2014 | Option Exercise | $4.45 | 11,000 | 48,950 | 663,734 | Feb 13, 2014, 08:40 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Jan 15, 2014 | Option Exercise | $2.80 | 45,800 | 128,208 | 731,634 | Jan 17, 2014, 04:22 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Dec 06, 2013 | Sale | $2.25 | 92,000 | 207,198 | 754,734 | Dec 10, 2013, 05:06 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Dec 09, 2013 | Option Exercise | $2.25 | 36,200 | 81,497 | 726,834 | Dec 10, 2013, 05:06 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Oct 01, 2013 | Sale | $2.34 | 70,000 | 164,010 | 743,734 | Oct 03, 2013, 04:27 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Sep 03, 2013 | Sale | $2.46 | 70,000 | 171,878 | 743,734 | Sep 05, 2013, 04:42 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Aug 01, 2013 | Sale | $2.46 | 70,000 | 172,092 | 743,734 | Aug 05, 2013, 04:35 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Jul 01, 2013 | Sale | $2.32 | 70,000 | 162,473 | 743,734 | Jul 03, 2013, 04:43 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Jun 03, 2013 | Sale | $2.25 | 250,000 | 563,637 | 833,734 | Jun 05, 2013, 04:39 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | May 06, 2013 | Sale | $2.27 | 20,000 | 45,350 | 533,547 | May 08, 2013, 05:53 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Jan 08, 2013 | Sale | $2.26 | 50,000 | 112,800 | 562,393 | Jan 10, 2013, 04:35 PM | |
| ATRS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Dec 04, 2012 | Sale | $2.25 | 50,000 | 112,507 | 562,393 | Dec 06, 2012, 04:41 PM | |
| AIS | ANTARES PHARMA, INC. | Wotton Paul K | President and CEO | Aug 24, 2010 | Buy | $1.50 | 10,000 | 15,000 | 312,937 | Aug 24, 2010, 04:11 PM |
Menu